Position history for Capital World Investors's holdings in VERTEX PHARMACEUTICALS INC
Capital World Investors holds 25.4M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $11.3B as of 2026-Q1. The position was decreased (-0.6% shares). VRTX represents 1.5% of Capital World Investors's portfolio.
Current Value
$11.3B
Current Shares
25.4M
Total Value Change
-$1.2B
Total Shares Change
-1.3M
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 25.4M |
-0.6% |
| $11.3B |
| 1.5% |
| $474.27 |
0 |
| 2025-Q4 | Decreased | 25.5M | -1.6% | $11.6B | 1.6% | $453.74 | 0 |
| 2025-Q3 | Decreased | 25.9M | -9.8% | $10.1B | 1.4% | $395.31 | 0 |
| 2025-Q2 | Increased | 28.7M | +0.7% | $12.8B | 1.9% | $441.30 | 50 |
| 2025-Q1 | Increased | 28.5M | +0.7% | $13.8B | 2.2% | $492.69 | 55 |
| 2024-Q4 | Increased | 28.3M | +5.7% | $11.4B | 1.7% | $399.35 | 53 |
| 2024-Q3 | Increased | 26.8M | +0.4% | $12.5B | 1.9% | $462.88 | 50 |
| 2024-Q2 | Increased | 26.7M | +4.5% | $12.5B | 2.0% | $468.72 | 57 |